AMGN241129P205000
- 0.00
- 0.000.00%
Amgen Newsroom
Amgen weight loss drugs have a remarkable effect of reducing 20% body weight, but with relatively high side effects, leading to a temporary large drop of over 12% during trading hours.
Although the weight loss effect of amgen's MariTide drug met expectations, the high side effects, lower than eli lilly and co's Zepbound, and the trial results falling below Wall Street's high expectations, led to amgen's stock price plunging over 12.3% on Tuesday, far behind eli lilly and co and novo-nordisk a/s, which benefited from the Biden policy rise at the same time. In a one-year trial, MariTide helped non-diabetic patients lose up to 20% of their weight, comparable to the maximum dose effect of eli lilly's Zepbound. However, the side effects are significant, with about 11% of patients dropping out of the trial due to side effects, higher than eli lilly's 7%.
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Transaction volume TOP 20 | Bitcoin falls below 0.091 million dollars, microstrategy drops over 12%; eli lilly and co rises over 4%, the Biden administration plans to include weight loss drugs in the health insurance subsidy program.
On Tuesday, the stock trading volume leader was nvidia, which rose by 0.66% with a trading volume of 25.738 billion USD. nvidia announced on Monday the launch of its music-generating AI model, Fugatto, claiming it to be the "most flexible sound machine in the world," capable of precisely controlling sound generation. nvidia stated that this tool is like a "swiss army knife" for the sound field, being able to create music, modify sounds, and flexibly mix various music, vocals, and sound effects, even generating unprecedented sounds. The second place went to Tesla, which fell by 0.11% with a trading volume of 20.929 billion USD. ubs group published a bearish research report on Tesla. The institutions stated,
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Amgen Options Spot-On: On November 26th, 133.57K Contracts Were Traded, With 212.37K Open Interest
On November 26th ET, $Amgen(AMGN.US)$ had active options trading, with a total trading volume of 133.57K options for the day, of which put options accounted for 52.7% of the total transactions, and
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline
Sector Update: Health Care Stocks Higher Late Afternoon
Amgen's Stock May See Worst Day in 24 Years as Weight-loss-drug Data Underwhelms
Unusual Options Activity: MTCH, TPR and Others Attract Market Bets, MTCH V/OI Ratio Reaches 142.4
EST Nov 26th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
US Equity Indexes Mixed in Midday Trading
Amgen Decline on MariTide Data Could Be Due to Lack of More Details
Amgen (NASDAQ:AMGN) Sinks Despite Positive MariTide Trial Data
Amgen, Boeing Share Losses Lead Dow's 200-Point Fall
US stock movement | Wall Street dissatisfied with the mid-term data of the weight-loss therapy MariTide, amgen (AMGN.US) drops over 10%.
As of the time of publication, the stock fell more than 10%, closing at $262.37.
Amgen Down Over 10%, on Pace for Largest Percent Decrease Since October 2000 -- Data Talk
Deutsche Bank Maintains Amgen(AMGN.US) With Hold Rating, Raises Target Price to $305
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Amgen (AMGN.US) stated that its weight loss drug can help reduce body weight by up to 20%, but the stock price fell 10% in pre-market trading.
Amgen (AMGN.US) stated on Tuesday that in a key mid-stage trial one year later, its experimental weight loss injection MariTide helped obese patients lose an average of 20% of their weight. However, the stock price fell more than 11% in pre-market trading.